Vaginosis POC test gets CE mark, 11/17
November 2017—Mologic (Thurleigh, U.K.) received CE marking for its BVPro, a 15-minute point-of-care diagnostic that detects sialidase enzyme activity from a vaginal swab sample.
Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
iBio, TheoremDx partnership, 11/17
November 2017—iBio has partnered with TheoremDx to develop proteins for rapid diagnostic testing products. The collaboration will leverage the TheoremDx point-of-care diagnostic system and the protein development and manufacturing capabilities
FDA clears iCubate platform, 11/17
November 2017—Molecular diagnostic device company iCubate has earned FDA clearance for its iCubate platform, the iC-System, and its first clinical assay, the iC-GPC Assay, used for the rapid detection of pathogenic bacteria associated with bloodstream infection.
High-throughput water purification system, 11/17
November 2017—MilliporeSigma launched its Milli-Q HR 7000 series, a high-throughput water purification system that offers a uniquely connected and sustainable central pure water solution. The system ensures constant water quality and flow rate while reducing water consumption and running costs, as compared with other high-throughput reverse osmosis systems, and produces up to 13,000 liters of pure water daily.
Urinalysis testing device, 11/17
November 2017—Quantimetrix announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for the company’s Dipper POCT Urinalysis Control. The patent application is directed to a liquid holding apparatus for insertion of a test device into a test liquid. The invention includes various technical innovations relating to the formation and use of an in vitro diagnostic pouch device.
Small, dense LDL assay cleared, 11/17
November 2017—Denka Seiken has received FDA 510(k) clearance for its small, dense LDL cholesterol (sdLDL-C) assay, designed for use with automated chemistry analyzers.
Varicella zoster virus antigens, 11/17
November 2017—Binding Site’s Immunologicals Group has added two varicella zoster virus antigens to its line of products for in vitro diagnostic manufacturing and research applications. Both the standard VZV antigen and the VZV glycoprotein antigen have been designed for use as integral components within solid phase enzyme immunoassay test procedures.
Automated section mounting system, 11/17
November 2017—Aquaro Histology exhibited its AquaroASM, the company’s device for automating microtomy, at the 43rd Annual National Society for Histotechnology Symposium/Convention in September.
Commercializing novel IVDs book, 10/17
October 2017—Insight Pharma Reports has published Commercializing Novel IVDs: A Comprehensive Manual for Success by Harry Glorikian, MBA, who has more than 30 years in the global IVD field and in IVD innovation.
NWLP inks deal with Abbott, 10/17
October 2017—North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott have signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott’s Alinity ci and Alinity h series diagnostics instruments as well as its professional services and informatics solutions known as AlinIQ.